ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Glenmark to launch trial in solid tumours for its CD38xCD3 bispecific antibody GBR 1342
November 10, 2018The decision to expand clinical development of GBR 1342 was based on a recently completed ex vivo translational study in multiple solid tumours utilising the clinically validated CANscript platform, where treatment with GBR 1342 revealed predictive respon -
Glenmark to launch trial in solid tumours for its CD38xCD3 bispecific antibody GBR 1342
November 10, 2018The decision to expand clinical development of GBR 1342 was based on a recently completed ex vivo translational study in multiple solid tumours utilising the clinically validated CANscript platform, where treatment with GBR 1342 revealed predictive respon
Pharma Sources Insight January 2025
